EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Norovirus-specific monoclonal antibodies that block histo-blood group antigen binding isolated from healthy donors

Sabina E W Leonard iD, Olivia C Powers, Parastoo Amlashi iD, Mark von Itzstein iD, Perry T Wasdin, Toma M Marinov, Alexandra A Abu-Shmais iD, Ivelin S Georgiev iD, Grant S Hansman iD

Journal of Virology · 2026

DOI: 10.1128/jvi.00497-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Sabina E W Leonard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Norovirus, Antibodies, Monoclonal, Blood Group Antigens, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human noroviruses are a leading cause of acute gastroenteritis, yet no licensed vaccine or antiviral is currently available. The extensive genetic diversity of noroviruses and the limited cross-protective immunity between genotypes complicate the development of broadly effective interventions. To systematically characterize norovirus-specific B cell responses from healthy individuals, we applied linking B cell receptor to antigen specificity through sequencing (LIBRA-seq) to peripheral blood mononuclear cells using a genetically diverse panel of norovirus capsid protruding (P) domain antigens. Antigen-specific B cells were identified at single-cell resolution and selected for recombinant monoclonal antibody (mAb) expression. A total of 25 norovirus-specific mAbs were generated and evaluated for binding breadth across multiple genogroup II (GII) genotypes. Binding analyses revealed substantial heterogeneity, with some mAbs displaying narrow, genotype-restricted recognition, whereas others exhibited broad cross-reactivity. Epitope competition assays using a subset of mAbs demonstrated both overlapping and distinct binding sites on the P domain. Functional activity, assessed using a surrogate neutralization assay measuring inhibition of histo-blood group antigen (HBGA) binding, showed that several broadly reactive antibodies inhibited virus-like particle attachment to HBGAs with variable potency across genotypes, whereas others exhibited genotype-restricted inhibition. Together, these results demonstrate that LIBRA-seq enables efficient mapping of human antibody repertoires to norovirus at the population level and reveals that natural exposure generates a diverse B-cell repertoire with varying specificity and functional breadth. IMPORTANCE Human noroviruses are the leading cause of acute viral gastroenteritis worldwide, yet individuals experience repeated infections throughout life, indicating that protective immunity is incomplete and remains poorly understood. In this study, we applied the high-throughput LIBRA-seq approach to systematically map the norovirus-specific antibody repertoire in healthy human donors, enabling the identification of monoclonal antibodies that recognize and functionally inhibit clinically relevant genotypes. This work provides new insight into the breadth and specificity of naturally acquired humoral immunity by establishing a comprehensive framework for analyzing antigen-specific B cell responses in the general population and generates a well-defined panel of human antibodies that will be useful for future studies of norovirus immunity, vaccine evaluation, and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NorovirusAntibodies, MonoclonalBlood Group AntigensAntibodies, ViralHumansCaliciviridae InfectionsCross ReactionsB-LymphocytesGenotypeCapsid ProteinsLeukocytes, MononuclearGastroenteritisHealthy VolunteersAntigens, ViralProtein Binding

Stichwörter der Autor:innen

antibodyhisto-blood group antigennorovirus

Substanzen

Antibodies, MonoclonalBlood Group AntigensAntibodies, ViralCapsid ProteinsAntigens, Viral

Autor:innen und Institutionen

  • Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Queensland, Australia.
  • Center for Computational Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Sabina E W Leonard, Parastoo Amlashi, Mark von Itzstein, Alexandra A Abu-Shmais, Ivelin S Georgiev, Grant S Hansman

Förderung

  • NIAID NIH HHS

Zitieren

APA

Leonard, S. E. W., Powers, O. C., Amlashi, P., von Itzstein, M., Wasdin, P. T., Marinov, T. M., Abu-Shmais, A. A., Georgiev, I. S., & Hansman, G. S. (2026). Norovirus-specific monoclonal antibodies that block histo-blood group antigen binding isolated from healthy donors. Journal of Virology. https://doi.org/10.1128/jvi.00497-26

Vancouver

Leonard SEW, Powers OC, Amlashi P, von Itzstein M, Wasdin PT, Marinov TM, et al. Norovirus-specific monoclonal antibodies that block histo-blood group antigen binding isolated from healthy donors. Journal of Virology. 2026. doi:10.1128/jvi.00497-26

BibTeX
@article{Leonard2026,
  author = {Leonard, Sabina E W and Powers, Olivia C and Amlashi, Parastoo and von Itzstein, Mark and Wasdin, Perry T and Marinov, Toma M and Abu-Shmais, Alexandra A and Georgiev, Ivelin S and Hansman, Grant S},
  title = {Norovirus-specific monoclonal antibodies that block histo-blood group antigen binding isolated from healthy donors},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.00497-26}
}
Kostenlos starten →